Alfonso Otero González
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Alfonso Otero González has a total of 30 co-authors. Here are the top co-authors by number of shared publications:
Ivan Gilberto Arenas Moncaleano
Servicio de Nefrología, Complexo Hospitalario Universitario de Ourense, Ourense , España
4 shared publicationsMaría Paz Borrajo Prol
Servicio de Nefrología, Centro Hospitalario Universitario de Ourense, Ourense, Spain
4 shared publicationsSilvia Uribe Moya
Servicio de Nefrología, Complexo Hospitalario Universitario de Ourense, Ourense , España
4 shared publicationsA.L.M. de Francisco
2 shared publicationsAlfonso Iglesias Forneiro
2 shared publicationsCristina Pérez Melón
2 shared publications
Latest Publications
- Open Access
- 10 August 2023
- Published by Elsevier in Nefrología
- Vol. 44 (3) , 331-337
Enfermedad renal crónica, diálisis y cambio climático
- 10 August 2023
- Published by Elsevier in Nefrología
- Vol. 44 (3) , 331-337
Open AccessEnfermedad renal crónica, diálisis y cambio climático
- 9 March 2023
- Published by Elsevier in Hipertensión y Riesgo Vascular
- Vol. 40 (1) , 1-4
SINDROME NEFROTICO Y EMBARAZO
- 9 March 2023
- Published by Elsevier in Hipertensión y Riesgo Vascular
- Vol. 40 (1) , 1-4
SINDROME NEFROTICO Y EMBARAZO
- 9 August 2020
- Published by Springer Nature in Current Cardiology Reports
- Vol. 22 (10) , 1-15
Does Timing of Antihypertensive Medication Dosing Matter?
Purpose of Review Current hypertension guidelines do not provide recommendation on when-to-treat. Herein, we review the current evidence on ingestion-time differences of hypertension medications in blood pressure (BP)–lowering effects and prevention of cardiovascular disease (CVD) events. Recent Findings The vast (81.6%) majority of the 136 published short-term treatment-time trials document benefits, including enhanced reduction of asleep BP and increased sleep-time relative BP decline (dipping), when hypertension medications and their combinations are ingested before sleep rather than upon waking. Long-term outcome trials further document bedtime hypertension therapy markedly reduces risk of major CVD events. The inability of the very small 18.4% of the published trials to substantiate treatment-time difference in effects is mostly explained by deficiencies of study design and conduct. Summary Our comprehensive review of the published literature reveals no single study has reported better benefits of the still conventional, yet scientifically unjustified, morning than bedtime hypertension treatment scheme.
- 9 August 2020
- Published by Springer Nature in Current Cardiology Reports
- Vol. 22 (10) , 1-15
Does Timing of Antihypertensive Medication Dosing Matter?
Purpose of Review Current hypertension guidelines do not provide recommendation on when-to-treat. Herein, we review the current evidence on ingestion-time differences of hypertension medications in blood pressure (BP)–lowering effects and prevention of cardiovascular disease (CVD) events. Recent Findings The vast (81.6%) majority of the 136 published short-term treatment-time trials document benefits, including enhanced reduction of asleep BP and increased sleep-time relative BP decline (dipping), when hypertension medications and their combinations are ingested before sleep rather than upon waking. Long-term outcome trials further document bedtime hypertension therapy markedly reduces risk of major CVD events. The inability of the very small 18.4% of the published trials to substantiate treatment-time difference in effects is mostly explained by deficiencies of study design and conduct. Summary Our comprehensive review of the published literature reveals no single study has reported better benefits of the still conventional, yet scientifically unjustified, morning than bedtime hypertension treatment scheme.
- Open Access
- 1 January 2018
- Published by Elsevier in Nefrología (English Edition)
- Vol. 38 (1) , 107-108
Obesity and kidney function; epidemiological study data: Prevalence of chronic kidney disease in Spain. EPIRCE study
- 1 January 2018
- Published by Elsevier in Nefrología (English Edition)
- Vol. 38 (1) , 107-108
Open AccessObesity and kidney function; epidemiological study data: Prevalence of chronic kidney disease in Spain. EPIRCE study
- Open Access
- 1 January 2018
- Published by Elsevier in Nefrología
- Vol. 38 (1) , 107-108
Obesidad y funcion renal .datos del estudio epidemiologico: Prevalencia de la enfermedad renal cronica en España. Estudio EPIRCE
- 1 January 2018
- Published by Elsevier in Nefrología
- Vol. 38 (1) , 107-108
Open AccessObesidad y funcion renal .datos del estudio epidemiologico: Prevalencia de la enfermedad renal cronica en España. Estudio EPIRCE
- Open Access
- 1 November 2015
- Published by Elsevier in Nefrología (English Edition)
- Vol. 35 (6) , 562-566
Survival for haemodialysis vs. peritoneal dialysis and technique transference. Experience in Ourense, Spain, from 1976 to 2012
- 1 November 2015
- Published by Elsevier in Nefrología (English Edition)
- Vol. 35 (6) , 562-566
Open AccessSurvival for haemodialysis vs. peritoneal dialysis and technique transference. Experience in Ourense, Spain, from 1976 to 2012
- Open Access
- 1 November 2015
- Published by Elsevier in Nefrología (English Edition)
- Vol. 35 (6) , 572-577
Hyperbaric index in the primary prevention of hypertensive complications in high-risk pregnancy
- 1 November 2015
- Published by Elsevier in Nefrología (English Edition)
- Vol. 35 (6) , 572-577
Open AccessHyperbaric index in the primary prevention of hypertensive complications in high-risk pregnancy
- Open Access
- 1 November 2015
- Published by Elsevier in Nefrología
- Vol. 35 (6) , 562-566
Supervivencia en hemodiálisis vs. diálisis peritoneal y por transferencia de técnica. Experiencia en Ourense 1976-2012
- 1 November 2015
- Published by Elsevier in Nefrología
- Vol. 35 (6) , 562-566
Open AccessSupervivencia en hemodiálisis vs. diálisis peritoneal y por transferencia de técnica. Experiencia en Ourense 1976-2012
- Open Access
- 1 November 2015
- Published by Elsevier in Nefrología
- Vol. 35 (6) , 572-577
Índice hiperbárico en la prevención primaria de las complicaciones hipertensivas del embarazo de alto riesgo
- 1 November 2015
- Published by Elsevier in Nefrología
- Vol. 35 (6) , 572-577
Open AccessÍndice hiperbárico en la prevención primaria de las complicaciones hipertensivas del embarazo de alto riesgo
- Top Cited PapersOpen Access
- 16 October 2013
- Published by Springer Nature in BMC Endocrine Disorders
- Vol. 13 (1) , 47
Insulin resistance (HOMA-IR) cut-off values and the metabolic syndrome in a general adult population: effect of gender and age: EPIRCE cross-sectional study
Insulin resistance has been associated with metabolic and hemodynamic alterations and higher cardio metabolic risk. There is great variability in the threshold homeostasis model assessment of insulin resistance (HOMA-IR) levels to define insulin resistance. The purpose of this study was to describe the influence of age and gender in the estimation of HOMA-IR optimal cut-off values to identify subjects with higher cardio metabolic risk in a general adult population.
- 16 October 2013
- Published by Springer Nature in BMC Endocrine Disorders
- Vol. 13 (1) , 47
Top Cited PapersOpen AccessInsulin resistance (HOMA-IR) cut-off values and the metabolic syndrome in a general adult population: effect of gender and age: EPIRCE cross-sectional study
Insulin resistance has been associated with metabolic and hemodynamic alterations and higher cardio metabolic risk. There is great variability in the threshold homeostasis model assessment of insulin resistance (HOMA-IR) levels to define insulin resistance. The purpose of this study was to describe the influence of age and gender in the estimation of HOMA-IR optimal cut-off values to identify subjects with higher cardio metabolic risk in a general adult population.